Shareholders' equity · 2016–2025
Kiniksa Pharmaceuticals International shareholders' equity
$568M+29.5% · FY2025
Kiniksa Pharmaceuticals International (KNSA) reported $568M in shareholders' equity for fiscal 2025, +29.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $568M | +29.5% | Open → |
| FY20242024-12-31 | $438M | −0.1% | Open → |
| FY20232023-12-31 | $439M | +10.8% | Open → |
| FY20222022-12-31 | $396M | +114.1% | Open → |
| FY20212021-12-31 | $185M | −40.7% | Open → |
| FY20202020-12-31 | $312M | +38.4% | Open → |
| FY20192019-12-31 | $225M | −19.3% | Open → |
| FY20182018-12-31 | $279M | +$369M | Open → |
| FY20172017-12-31 | −$89.7M | −$64.0M | Open → |
| FY20162016-12-31 | −$25.7M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Kiniksa Pharmaceuticals International shareholders' equity |url=https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Kiniksa Pharmaceuticals International shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/shareholders-equityBibTeX
@misc{companiesranked-en-company-kiniksa-pharmaceuticals-international-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Kiniksa Pharmaceuticals International shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/kiniksa-pharmaceuticals-international/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001104659-26-087545 · July 28, 2026
{{cite web |title=Kiniksa Pharmaceuticals International shareholders' equity — 10-Q (0001104659-26-087545) |url=https://www.sec.gov/Archives/edgar/data/1730430/000110465926087545/knsa-20260630x10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-28}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.